Editorial: Model organisms in experimental pharmacology and drug discovery

dc.contributor.authorNainu, F
dc.contributor.authorJota-Baptista, C
dc.contributor.authorFaustino-Rocha, Ana I
dc.contributor.authorOliveira, PA
dc.date.accessioned2024-10-10T16:16:48Z
dc.date.available2024-10-10T16:16:48Z
dc.date.issued2023
dc.description.abstractModel organisms are non-human species that have long been recognized as one of the crucial pillars in research, particularly in the field of experimental pharmacology and drug discovery (Hau, 2008). These organisms are widely employed in preclinical settings, providing a convenient way to model human diseases, explore the prospective pharmacological and toxicological effects of drug candidates, and elucidate the uncharted mechanisms of their action (Jota Baptista et al., 2022). Hence, studies using model organisms are essential for achieving scientifically sound progress within the field.por
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailanafaustino@uevora.pt
dc.identifier.authoremailnd
dc.identifier.citationNainu F, Jota-Baptista C, Faustino-Rocha A, PA Oliveira. 2023. Editorial: Model organisms in experimental pharmacology and drug discovery. Frontiers in Pharmacology 14: 1143934. Doi: 10.3389/fphar.2023.1143934.por
dc.identifier.urihttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1143934/full
dc.identifier.urihttp://hdl.handle.net/10174/37419
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherFrontiers in Pharmacologypor
dc.rightsopenAccesspor
dc.titleEditorial: Model organisms in experimental pharmacology and drug discoverypor
dc.typearticlepor

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fphar-14-1143934.pdf
Size:
528.24 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
3.89 KB
Format:
Item-specific license agreed upon to submission
Description: